Family Medicine Doctors in Kearny, AZ Accepting Medicare
3 Family Medicine doctors found. Showing 1 - 3
 Dr. Lois Genell Fister Steele, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 100 Tilbury Drive, Kearny, AZ 85237 Phone: 520-363-5573 Fax: 520-363-5611 |
 Jeff Crawford, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 351 Airport Road, Kearny, AZ 85237 Phone: 520-363-9772 Fax: 520-363-9774 |
Virginia Rutz, D.O. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 100 Tilbury Dr., Kearny, AZ 85237 Phone: 520-363-5573 Fax: 520-363-5611 |
News Archive
Ophthotech announces data from Fovista Phase 2b trial on wet AMD
Ophthotech Corporation today announced that data from a large, prospective, randomized, controlled Phase 2b clinical trial of Ophthotech's Fovista anti-PDGF therapy (1.5 mg) in patients with neovascular age-related macular degeneration (wet AMD) will be presented during Retina Subspecialty Day at the American Academy of Ophthalmology Annual Meeting (AAO) on Sat., Nov. 10, 2012 at 9:15 a.m.
Women and cancer today
Experts have warned that women who have their breasts removed out of fear of a high hereditary risk of breast cancer may be doing so needlessly. Genetic tests like for the BRCA mutations have predicted a high risk of getting breast cancer in women with many breast cancer sufferers among their first degree relatives. Earlier studies suggest the risk of the mutation to predict the cancer 87% of the time. Now experts want that this is an overestimate.
Meat Institute defends hot dogs in recent pancreatic cancer study
In response to the report released today at the American Association for Cancer Research in Anaheim, California, attempting to link processed meats to pancreatic cancer, James L. Hodges, President of the American Meat Institute Foundation made the following comment:
Daily sugar intake in European children is up to three times more than the maximum recommended level
European experts say free sugar intake in children in European countries outstrips the recommended maximum daily intake by up to 3 times and could be causing serious health problems, including contributing to the global obesity epidemic.
EMA CHMP issues positive opinion to MSD's REMICADE for treatment of pediatric UC
MSD today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) adopted a positive opinion recommending the use of REMICADE (infliximab) in the treatment of severely active ulcerative colitis (UC) in pediatric patients ages 6 to 17 years, who have had an inadequate response to conventional therapy, including corticosteroids and 6-mercaptopurine or azathioprine, or who are intolerant to or have medical contraindications for such therapies.
› Verified 7 days ago